Gut microbiome emerges as key clue to cancer drug side effects

Researchers at the South Australian Health and Medical Research Institute have identified how the gut microbiome influences side effects of the cancer drug bortezomib. The study links the treatment to nerve-immune signaling changes, offering a potential path to mitigating painful neuropathy and gastrointestinal issues for patients.